Catch pre-market movers with AI signals.
TRML(Quitar la ciudad)
Tourmaline Bio (TRML) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Tourmaline Bio market cap is -- and enterprise value is --.
Share Statistics
Tourmaline Bio has 25.76M shares outstanding, with a free float of 16.80M.
Valuation Ratios
Tourmaline Bio's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Tourmaline Bio debt-to-equity ratio is 0 and debt-to-assets ratio is 0.04.
Liquidity
Tourmaline Bio's current ratio is 24.68, quick ratio is 24.68, and cash ratio is 23.7, showing its short-term liquidity position.
Return on Capital
Tourmaline Bio's ROE is -29.62%, ROA is -28.81%, and ROIC is -34.29%, showing its return on capital profile.
Profitability
Tourmaline Bio gross margin is --, operating margin is --, and net margin is --.
Operating Efficiency
Tourmaline Bio's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
Tourmaline Bio's revenue is --, gross profit is --, net income is -88.47M, and EBITDA is -102.41M.
Balance Sheet
Tourmaline Bio's total debt is 0, net debt is 0, total equity is 259.19M, and cash is 239.23M.
Cash Flow Statement
Tourmaline Bio's operating cash flow is -86.28M, free cash flow is -86.30M, and CapEx is --.
Dividends & Yields
Tourmaline Bio dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Tourmaline Bio's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A late-stage clinical biotechnology company
Per Share Metrics
Tourmaline Bio's EPS is -3.44, book value per share is 10.09, and free cash flow per share is --.
